Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 10/2012

01-10-2012 | Editorial

PET/MRI and the revolution of the third eye

Authors: Luigi Mansi, Andrea Ciarmiello, Vincenzo Cuccurullo

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 10/2012

Login to get access

Excerpt

The 20th century diagnostic imaging scenario almost for the whole of its existence was divided into two well-separated universes: (1) the morphostructural, in which information on anatomy and structures are acquired, with pathology as the gold standard, and (2) the functional, in which normal and altered functions are analysed, with pathophysiology as the reference. …
Literature
1.
Bailey TM, Vealé BL. Advanced computed tomography technology and patient dose: a literature review. Radiol Manage. 2011;33(5):43–6.PubMed
2.
Fanti S, Farsad M, Mansi L. PET-CT beyond FDG. Berlin: Springer Verlag; 2010.
3.
Rice SL, Roney CA, Daumar P, Lewis JS. The next generation of positron emission tomography radiopharmaceuticals in oncology. Semin Nucl Med. 2011;41(4):265–82.PubMedCrossRef
4.
Groves AM, Shastry M, Rodriguez-Justo M, Malhotra A, Endozo R, Davidson T, et al. 18F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. Eur J Nucl Med Mol Imaging. 2011;38(1):46–52.PubMedCrossRef
5.
Arnaldi D, Morbelli S, Morrone E, Campus C, Nobili F. Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging. Q J Nucl Med Mol Imaging. 2012;1:55–67.
6.
7.
De Stefano N, Filippi M, Miller D, Pouwels PJ, Rovira A, Gass A, et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology. 2007;69(20):1942–52.PubMedCrossRef
8.
Geraldes CF, Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging. 2009;4(1):1–23.PubMedCrossRef
9.
Modo M, Hoehn M, Bulte JW. Cellular MR imaging. Mol Imaging. 2005;4(3):143–64.PubMed
10.
Tunariu N, Kaye SB, Desouza NM. Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies? Br J Cancer. 2012;106(4):619–28.PubMedCrossRef
11.
Tournier JD, Mori S, Leemans A. Diffusion tensor imaging and beyond. Magn Reson Med. 2011;65(6):1532–56.PubMedCrossRef
12.
Abraham T, Feng J. Evolution of brain imaging instrumentation. Semin Nucl Med. 2011;41(3):202–19.PubMedCrossRef
13.
Gore JC, Manning HC, Quarles CC, Waddell KW, Yankeelov TE. Magnetic resonance in the era of molecular imaging of cancer. Magn Reson Imaging. 2011;29(5):587–600.PubMedCrossRef
14.
Todd-Pokropek A. Advances in computers and image processing with applications in nuclear medicine. Q J Nucl Med. 2002;46(1):62–9.PubMed
15.
Israel O, Keidar Z, Iosilevsky G, Bettman L, Sachs J, Frenkel A. The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med. 2001;31(3):191–205.PubMedCrossRef
16.
Lucignani G, De Palma D. PET/CT in paediatric oncology: clinical usefulness and dosimetric concerns. Eur J Nucl Med Mol Imaging. 2011;38(1):179–84.PubMedCrossRef
17.
Bettinardi V, Picchio M, Di Muzio N, Gianolli L, Messa C, Gilardi MC. PET/CT for radiotherapy: image acquisition and data processing. Q J Nucl Med Mol Imaging. 2010;54(5):455–75.PubMed
18.
Pichler BJ, Judenhofer MS, Wehrl HF. PET/MRI hybrid imaging: devices and initial results. Eur Radiol. 2008;18(6):1077–86.PubMedCrossRef
19.
Metadata
Title
PET/MRI and the revolution of the third eye
Authors
Luigi Mansi
Andrea Ciarmiello
Vincenzo Cuccurullo
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 10/2012
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-012-2185-x

Other articles of this Issue 10/2012

European Journal of Nuclear Medicine and Molecular Imaging 10/2012 Go to the issue

Original Article

The value of 18F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis

Image of the Month

Head-to-head comparison between SRS, 18F-FDG and 18F-FDOPA PET/CT in a patient with recurrent SDHC-related jugular paraganglioma

Short Communication

FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis

Original Article

Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy

Society Communications

51st ESNM Seminar – Technologists Session, June 2, 2012, Varna, Bulgaria

Original Article

Association of left ventricular mechanical dyssynchrony with survival benefit from revascularization: a study of gated positron emission tomography in patients with ischemic LV dysfunction and narrow QRS